LIVZON PHARMA
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1985-01-26
- Employees
- 8.9K
- Market Cap
- -
- Website
- http://www.livzon.com.cn
- Introduction
The company was founded in January 1985. It is a comprehensive pharmaceutical group company integrating R&D, production and sales of pharmaceutical products, and is an A+H listed company. The company regards R&D innovation as the cornerstone of sustainable development, and continues to pay attention to new molecules and cutting-edge technologies in the globa...
Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
- Conditions
- Interventions
- First Posted Date
- 2021-09-20
- Last Posted Date
- 2023-04-25
- Lead Sponsor
- Livzon Pharmaceutical Group Inc.
- Target Recruit Count
- 43
- Registration Number
- NCT05050474
- Locations
- 🇨🇳
Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, China
Single-dose Escalation Study of SQ-001 Infusion to Characterize the PK Profiles of Major Sentinel Compounds in Healthy Adult Volunteers in US
- Conditions
- Interventions
- First Posted Date
- 2019-07-19
- Last Posted Date
- 2019-07-19
- Lead Sponsor
- Livzon Pharmaceutical Group Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT04026321
- Locations
- 🇺🇸
Clinical Pharmacology of Miami, Inc., Miami, Florida, United States
Shenqi Fuzheng Injection for the Treatment of Cancer-related Fatigue in Patients(BCS) With Digestive Tract .
- Conditions
- Interventions
- First Posted Date
- 2018-03-07
- Last Posted Date
- 2018-03-07
- Lead Sponsor
- Livzon Pharmaceutical Group Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT03456609
- Locations
- 🇨🇳
First affiliated hospital of guangzhou university of traditional Chinese medicine, Guangzhou, Guangdong, China
Shenqi Fuzheng Injection for the Treatment of Cancer-related Fatigue in Chemo Patients With Digestive Tract .
- First Posted Date
- 2018-03-06
- Last Posted Date
- 2018-03-06
- Lead Sponsor
- Livzon Pharmaceutical Group Inc.
- Target Recruit Count
- 270
- Registration Number
- NCT03455205
- Locations
- 🇨🇳
First affiliated hospital of guangzhou university of traditional Chinese medicine, Guangzhou, Guangdong, China
IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
- First Posted Date
- 2017-12-05
- Last Posted Date
- 2017-12-06
- Lead Sponsor
- Livzon Pharmaceutical Group Inc.
- Target Recruit Count
- 180
- Registration Number
- NCT03362268
Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
- Conditions
- Interventions
- First Posted Date
- 2017-12-05
- Last Posted Date
- 2017-12-06
- Lead Sponsor
- Livzon Pharmaceutical Group Inc.
- Target Recruit Count
- 540
- Registration Number
- NCT03362281
LZM009 to Treat Patients With Advanced Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2017-09-18
- Last Posted Date
- 2019-08-02
- Lead Sponsor
- Livzon Pharmaceutical Group Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03286296
- Locations
- 🇺🇸
South Texas Accelerated Research Therapeutics, San Antonio, Texas, United States
🇺🇸START Midwest, Grand Rapids, Michigan, United States
Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori
- Conditions
- Interventions
- First Posted Date
- 2016-08-19
- Last Posted Date
- 2016-08-19
- Lead Sponsor
- Livzon Pharmaceutical Group Inc.
- Registration Number
- NCT02873065
Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients
- Conditions
- Interventions
- First Posted Date
- 2016-08-09
- Last Posted Date
- 2016-08-09
- Lead Sponsor
- Livzon Pharmaceutical Group Inc.
- Target Recruit Count
- 550
- Registration Number
- NCT02860624
Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients
- Conditions
- Interventions
- First Posted Date
- 2016-07-28
- Last Posted Date
- 2016-07-28
- Lead Sponsor
- Livzon Pharmaceutical Group Inc.
- Target Recruit Count
- 408
- Registration Number
- NCT02847455